Key Takeaways
1. J&J's Iconic Trust Masked a Dark Reality.
If there is a more American—quintessentially American—company than Johnson & Johnson, I do not know what it is.
A beloved brand. For generations, Johnson & Johnson cultivated an image of trust and care, deeply associated with iconic products like Johnson's Baby Powder and Tylenol. This emotional bond, particularly with the mother-baby relationship, served as a powerful protective halo, fostering consumer loyalty and admiration from professionals and regulators.
The Credo's promise. Central to this image was the J&J Credo, promising responsibility first to those who use their products, not shareholders. The company's handling of the 1982 Tylenol poisoning crisis became a legendary example of prioritizing safety over profit, taught widely as a model of ethical corporate behavior.
A stark contrast. However, beneath this pristine reputation, the author argues, lay a pattern of prioritizing profits, concealing dangers, and engaging in illegal marketing tactics. This disconnect between mythology and reality became increasingly apparent as the company grew into the world's largest healthcare conglomerate.
2. Baby Powder: Decades of Known Asbestos Contamination Concealed.
For Johnson & Johnson, virtually none of this was new.
Early warnings ignored. As early as the 1950s, J&J was aware that its talc, sourced from mines often co-located with asbestos deposits, contained asbestos impurities. Internal documents from the late 1960s explicitly discussed the presence of tremolite asbestos and the potential for litigation related to lung disease.
Discrediting science. When independent scientists in the 1970s found asbestos in J&J's Baby Powder and linked talc use to ovarian cancer, the company launched aggressive campaigns to discredit the research and influence regulatory bodies. They hired consultants who had found asbestos in their own tests but pressured them to suppress findings.
Lies and cover-ups. J&J publicly denied the presence of asbestos while privately acknowledging it. They manipulated testing standards, destroyed documents, and provided false sworn testimony for decades. This concealment continued even as evidence mounted and lawsuits accumulated, prioritizing the "sacred cow" brand over public health.
3. The Tylenol Myth: Crisis Management Hid Deeper Issues.
It was a bitter irony that the gentle, loving relationship between mother and child should somehow be a factor in the comeback phase of a crime of evil-minded brutality.
A PR triumph. J&J's swift, costly recall of Tylenol capsules in 1982 after cyanide tamperings is widely hailed as a masterclass in ethical crisis management, solidifying the company's reputation for putting people first. This response undoubtedly saved lives and led to industry-wide tamper-proof packaging.
Undermining the narrative. However, the author points to flaws in this heroic tale:
- Tylenol had experienced prior tamperings, suggesting the crisis wasn't unforeseen.
- J&J initially resisted a nationwide recall, agreeing only after a copycat poisoning became public.
- Evidence suggests the contamination may have occurred higher up the distribution chain (wholesale boxes found), not just on store shelves, potentially implicating J&J's system security.
A corrupt regulator. The FDA's response was also problematic, quickly absolving J&J and surrendering investigative roles, partly influenced by a commissioner later found to have secretly taken money from drug companies. This "love fest" between J&J and the FDA, while leading to positive packaging changes, also shielded the company from deeper scrutiny regarding its distribution vulnerabilities.
4. Risperdal: Illegally Marketing a Dangerous Drug to Vulnerable Patients.
Thus was born “Sell to the Symptoms.”
Beyond schizophrenia. Approved only for schizophrenia, Risperdal's sales goals necessitated expanding its use to other conditions. J&J implemented a strategy to market the drug based on symptoms common across many psychiatric issues (anxiety, agitation, hostility), not just the approved diagnosis.
Targeting the vulnerable. This illegal "Sell to the Symptoms" approach aggressively targeted children and the elderly, populations where Risperdal was not approved and carried significant risks:
- Children: Marketed for behavioral disorders, despite known risks of severe weight gain and gynecomastia (male breast growth). Internal studies showed one in ten boys developed permanent breast tissue.
- Elderly: Marketed for dementia-related psychosis, despite trials showing little benefit and increased risks of strokes, heart attacks, and death.
Ignoring and concealing risks. J&J executives knew of these severe side effects from their own trials but suppressed the data, manipulated study results, and lied to the FDA and doctors. Sales reps were even told to suggest diagnosing dementia patients with schizophrenia to avoid regulatory scrutiny.
5. Corrupting Doctors and Institutions Fueled Harmful Prescribing.
Every dollar given to doctors led to between $3.50 and $5.00 in additional drug sales.
The payoff machine. With the rise of data tracking, J&J and other drugmakers learned that paying doctors directly yielded massive returns. This led to a systematic effort to funnel money to physicians through speaking fees, consulting gigs, lavish gifts, and "seeding trials" disguised as research.
Undermining science. This financial influence corrupted medical practice and research:
- Doctors were incentivized to prescribe based on profit, not patient need or scientific evidence.
- Academics were paid to conduct biased studies and ghostwrite articles promoting off-label uses.
- Patient advocacy groups (like NAMI) and state officials were paid to lobby for policies favoring expensive drugs like Risperdal, even at the cost of cutting services for the poor.
FDA's complicity. The FDA, increasingly reliant on industry user fees, largely ceased policing illegal marketing and bribery. This created an environment where companies factored fines into the cost of doing business, knowing the financial rewards of illegal promotion far outweighed potential penalties.
6. J&J's Hidden Role in Driving the Opioid Epidemic.
J & J was clearly the kingpin of the opioid epidemic, not Purdue Pharma.
Supplier and marketer. While Purdue Pharma is infamous for OxyContin, J&J played a crucial, often overlooked, role in the opioid crisis. It was the largest supplier of key opioid ingredients (like oxycodone) in the U.S., achieved partly by engineering a high-yield "Norman" poppy in Tasmania.
Copying Purdue's playbook. After OxyContin's addiction crisis became public, J&J aggressively marketed its fentanyl patch, Duragesic, and later Nucynta, using the same false claims of low addiction risk that Purdue had pioneered.
- J&J sales reps cited flawed data (like DAWN) to convince doctors fentanyl was less prone to abuse than oral opioids.
- Internal plans targeted high-risk patients and aimed to extend treatment duration, directly fueling addiction.
Profit over public health. Unlike Purdue, J&J didn't need opioid sales for survival, yet it doubled down on aggressive marketing even as the death toll mounted. This demonstrated a ruthless indifference, prioritizing profits from addiction over the devastating public health consequences.
7. Medical Devices Rushed to Market Caused Widespread Injury.
Few doctors are aware that so many complex devices are approved without proof of safety or efficacy.
The 510(k) loophole. Unlike drugs, many high-risk medical devices are approved via a loophole (510(k)) by claiming similarity to devices approved before 1976, often without human testing. This allowed J&J to rush potentially dangerous devices to market.
Known dangers ignored. J&J launched devices with known, severe risks:
- Pinnacle Hip: A metal-on-metal hip implant similar to failed 1960s designs. Internal testing showed it shed toxic metal debris and failed at high rates, but J&J misrepresented data to the FDA and doctors.
- Prolift Mesh: A vaginal mesh kit for pelvic organ prolapse. Internal studies and inventor warnings before launch showed high rates of erosion, pain, and complications, yet J&J sold it without FDA approval and concealed the risks.
Profiting from failure. J&J not only sold defective devices but profited from the surgeries needed to remove and replace them. They also used payments to surgeons to encourage the use of these problematic implants and suppress reporting of complications.
8. The FDA: A Captive Regulator Failed to Protect the Public.
In truth, no major government agency has failed as fully, frequently, or consistently as the FDA.
Industry funding and influence. The FDA's increasing reliance on user fees from the industries it regulates compromised its independence. This financial dependence, coupled with a revolving door of personnel between the agency and industry, led to regulatory capture.
Failure to enforce. The FDA consistently failed to act as a tough cop:
- It ignored or delayed action on illegal marketing, known product contamination (Baby Powder, Tylenol), and dangerous side effects (Tylenol, Risperdal, Duragesic, Ortho Evra).
- It allowed devices to be approved without adequate testing and failed to mandate recalls despite mounting injuries.
- It issued statements favorable to J&J during litigation, undermining public health warnings.
A perpetuated myth. Despite its failures, the FDA maintains a public image as a rigorous, independent watchdog, a myth actively promoted by industry (including J&J) and often perpetuated by the media. This false perception shields companies from liability and lulls the public into a false sense of security about product safety.
9. J&J's Legal and Political Influence Ensured Impunity.
Johnson & Johnson has long been one of the biggest individual patrons of corporate law firms in the world.
Fighting accountability. J&J employed aggressive legal tactics to avoid responsibility for its misdeeds, including destroying documents, providing false testimony, and using maneuvers like the "Texas Two-Step" bankruptcy filing to shield assets from lawsuits.
Influence over the system. J&J's vast financial power and political connections allowed it to influence regulators, prosecutors, and the legal system:
- It lobbied successfully against stricter regulations and for laws limiting corporate liability.
- The revolving door between government agencies (FDA, DOJ) and law firms representing J&J hindered investigations and prosecutions.
- Prosecutors often declined to charge individual executives, citing lack of smoking-gun evidence or the difficulty of taking on a powerful conglomerate.
The Credo as camouflage. J&J's carefully crafted image and the widespread belief in its ethical standards served as a powerful shield, making it difficult for the public, media, and even some within the legal system to believe the extent of its misconduct.
10. The Covid Vaccine: A Failed Redemption Attempt.
Suddenly, the rarest of opportunities presented itself to the planet’s largest healthcare conglomerate—a chance to redeem itself by saving the world.
A high-profile effort. J&J's development of a single-shot Covid vaccine was presented as a chance to restore its reputation, marred by mounting lawsuits and scandals. CEO Alex Gorsky personally championed the effort, aligning his brand with the vaccine.
Manufacturing and safety failures. However, the vaccine effort was plagued by problems:
- A key manufacturing partner (Emergent BioSolutions) had severe quality control issues, leading to millions of contaminated doses being discarded.
- The vaccine was linked to rare but serious blood clots and Guillain-Barré syndrome, leading to pauses and warnings.
- Its efficacy proved lower than competitors, particularly against new variants.
Reputational damage. Despite initial hopes, the vaccine's problems and eventual withdrawal further damaged J&J's standing. The effort, intended to be a triumph, became another example of the company's struggles with quality control and transparency, ultimately becoming a "punch line."
11. J&J's History Reflects Systemic Failures in American Healthcare.
That Johnson & Johnson has gotten away with so much is a devastating indictment of the country’s for-profit healthcare model at large.
A pattern of harm. The detailed history of J&J's products reveals a consistent pattern: identifying profitable markets, rushing products to sale (often without adequate testing or approval), concealing known dangers, and using influence to evade accountability for resulting harm and deaths.
Systemic enablers. J&J's behavior was enabled by broader failures in the American system:
- A healthcare model where profit incentives often override patient well-being.
- A regulatory system (FDA) weakened by industry influence and lacking enforcement power.
- Institutions (medical societies, universities, media) compromised by financial ties to industry.
- A legal system where corporate power can overwhelm accountability.
The enduring myth. Despite evidence of widespread misconduct and significant harm, J&J's powerful brand and the complementary myth of a vigilant FDA allow it to maintain a positive public image and continue operating with relative impunity, highlighting deep flaws in American healthcare and capitalism.
Last updated:
FAQ
What is "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris about?
- Comprehensive exposé: The book investigates Johnson & Johnson’s (J&J) history, revealing a pattern of corporate misconduct, product safety issues, and regulatory failures across its consumer products, prescription drugs, and medical devices.
- Focus on public health impact: It connects J&J’s actions to major public health crises, including the opioid epidemic, talc-related cancers, and injuries from faulty medical devices.
- Corporate culture and ethics: Harris explores how J&J’s leadership and internal culture shifted from ethical ideals to profit-driven decisions, often at the expense of patient safety.
- Broader critique: The narrative also examines systemic problems in American healthcare, regulatory capture, and the media’s role in perpetuating J&J’s trusted image.
Why should I read "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris?
- Unveils hidden truths: The book exposes decades of concealed dangers, unethical practices, and corporate deception by one of the world’s most trusted healthcare companies.
- In-depth investigative journalism: Harris’s research, based on internal documents, court records, and interviews, provides a credible and comprehensive account that challenges the public’s perception of J&J.
- Insight into systemic issues: Readers gain a deeper understanding of how regulatory agencies, medical professionals, and advocacy groups can be compromised by industry influence.
- Empowers informed decisions: The book equips consumers, healthcare professionals, and policymakers with knowledge to advocate for reform and protect public health.
What are the key takeaways from "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris?
- Dual legacy of J&J: While J&J has produced life-saving products, it has also knowingly caused harm through contaminated talc, dangerous drugs, and faulty devices, often prioritizing profits over safety.
- Corporate gaslighting and ethical decay: The company’s use of its credo as a smokescreen masked a culture of deception, document hiding, and legal manipulation.
- Regulatory capture and failure: The FDA’s dependence on industry funding and close relationships with companies like J&J undermined its ability to protect public health.
- Need for reform: Harris advocates for independent safety monitoring, banning industry payments to doctors, and stronger legal accountability for executives.
How did Gardiner Harris uncover Johnson & Johnson’s handling of asbestos contamination in Baby Powder?
- Early awareness and concealment: J&J knew by the 1960s and 1970s that its talc products contained asbestos but led the industry to adopt testing standards that masked small amounts to avoid detection.
- Suppressing scientific findings: The company pressured researchers, hid documents, and discredited studies linking talc use to cancer, especially ovarian cancer.
- Legal and PR tactics: J&J maintained consumer trust through emotional branding and refused to fully acknowledge or warn about the risks until forced by lawsuits and regulatory action.
- Ongoing consequences: This concealment contributed to millions of injuries and deaths, with talc-related liabilities still impacting the company.
What does Gardiner Harris reveal about Johnson & Johnson’s marketing and sales tactics for prescription drugs like Risperdal and Procrit?
- Illegal and unethical marketing: J&J engaged in widespread off-label promotion, bribing doctors, and misleading advertising for drugs like Risperdal and Procrit, often ignoring or suppressing evidence of serious risks.
- “Sell to the symptoms” strategy: The company instructed sales reps to market drugs based on symptoms rather than approved diagnoses, targeting vulnerable groups such as children and the elderly.
- Financial incentives for doctors: J&J funneled cash, gifts, and consulting fees to physicians to boost prescriptions, creating conflicts of interest that compromised patient safety.
- Legal repercussions: These practices led to multiple lawsuits, criminal fines, and settlements, though executives often escaped personal accountability.
How did Johnson & Johnson contribute to the opioid epidemic, according to "No More Tears" by Gardiner Harris?
- Early warnings ignored: J&J was aware of the addiction risks of its opioid products like Duragesic but aggressively marketed them for chronic pain anyway.
- Copying Purdue Pharma’s tactics: The company adopted deceptive marketing strategies, falsely claiming fentanyl was non-addictive and targeting high-prescribing doctors, including pill mills.
- Manufacturing and supply control: J&J’s acquisition of Tasmanian poppy farms ensured control over opioid raw materials, facilitating large-scale production and distribution.
- Legal and public health impact: J&J faced lawsuits and substantial fines, highlighting its significant role in fueling the opioid crisis.
What were the major issues with Johnson & Johnson’s medical devices, such as metal-on-metal hip implants and vaginal mesh, as described by Gardiner Harris?
- Insufficient testing and concealment: J&J sold devices like the Pinnacle hip implant and Prolift vaginal mesh without adequate clinical testing, misrepresented design changes, and ignored high failure rates.
- Suppression of negative data: The company ghostwrote favorable studies, hid adverse events, and withheld risk information from surgeons and regulators.
- Bribery and unethical research: J&J incentivized surgeons to use these devices and engaged in unethical practices during clinical trials.
- Widespread harm: These actions led to thousands of injuries, billions in lawsuits, and lasting damage to patients’ health.
How does "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris critique the FDA’s role in regulating J&J and the pharmaceutical industry?
- Regulatory capture: The FDA’s funding model, heavily reliant on industry fees, compromised its independence and led to lax oversight.
- Ineffective post-market surveillance: The agency failed to monitor and act on safety signals after products reached consumers, allowing harmful drugs and devices to remain on the market.
- Cozy relationships with industry: The FDA often collaborated with J&J, sometimes ignoring or downplaying risks, and was slow to enforce penalties or demand transparency.
- Recommendations for reform: Harris suggests separating approval and safety monitoring functions and increasing public funding for the FDA.
Who is Alex Gorsky, and what role does he play in "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris?
- Key executive figure: Alex Gorsky is portrayed as the leader responsible for turning Risperdal into a blockbuster and later overseeing other divisions at J&J.
- Driving aggressive sales: Gorsky set unattainable sales goals that encouraged illegal marketing practices, including off-label promotion and kickbacks.
- Legacy and controversies: His tenure is linked to multiple J&J scandals, including opioid marketing, device failures, and the Covid-19 vaccine rollout.
- Public image vs. reality: While publicly celebrated for leadership, Gorsky’s career is marked by involvement in fraudulent activities and corporate misconduct.
What are the broader implications of Johnson & Johnson’s story in "No More Tears" for American healthcare and capitalism?
- Myth vs. reality: The book challenges the myth of J&J as a uniquely ethical American company, revealing how corporate interests often override public health and ethics.
- Regulatory capture: The FDA’s compromised role illustrates how regulatory agencies can become tools for industry rather than protectors of consumers.
- Healthcare consequences: Profit motives, marketing tactics, and regulatory failures contribute to public health crises, including cancer deaths, opioid addiction, and medical mistrust.
- Call for reform: The narrative highlights the need for systemic changes in healthcare regulation, transparency, and accountability.
What reforms does Gardiner Harris propose in "No More Tears: The Dark Secrets of Johnson & Johnson" to prevent future corporate misconduct in healthcare?
- Ban industry payments to doctors: To eliminate conflicts of interest, doctors should not accept money or gifts from drug and device companies while treating patients.
- Independent safety monitoring agency: A separate body from the FDA should oversee post-market product safety and marketing practices.
- Legal accountability for executives: Companies and their leaders must face criminal charges for lying under oath and concealing risks, with meaningful penalties.
- Media and systemic overhaul: Journalists and institutions must critically examine corporate influence and the for-profit healthcare model to foster transparency and public trust.
What are the most notable quotes from "No More Tears: The Dark Secrets of Johnson & Johnson" by Gardiner Harris, and what do they mean?
- "Trust Is Our Product": This phrase from a J&J slide deck encapsulates how the company’s brand relied on emotional trust, especially through products like Baby Powder, symbolizing the mother-baby bond.
- "The chink in their armor": Dr. Selikoff’s remark about asbestos exposure in talc products highlights the vulnerability in J&J’s defense and the hidden dangers consumers faced.
- "Miracle-Gro for cancer": Dr. Otis Brawley’s description of EPO’s effect on tumors captures the tragic irony of a drug intended to help cancer patients actually promoting tumor growth.
- Quotes as insight: These statements underscore the gap between J&J’s public image and the scientific reality, illustrating the deadly consequences of corporate and regulatory failures.
Review Summary
No More Tears exposes Johnson & Johnson's history of unethical practices, including selling dangerous products like asbestos-laced baby powder and ineffective medications. The book reveals J&J's role in the opioid crisis and their influence over the FDA. Readers found the exposé well-researched, shocking, and infuriating. Many praised the author's thorough investigation and compelling writing style. While some found certain sections less engaging, most agreed it's an important read that raises questions about corporate accountability and consumer trust in the healthcare industry.
Similar Books
Immersive
Download PDF
Download EPUB
.epub digital book format is ideal for reading ebooks on phones, tablets, and e-readers.
